期刊文献+

Adefovir抗乙型肝炎病毒的体外实验研究

Study of the anti-HBV action of Adefovir in vitro
下载PDF
导出
摘要 目的 在体外细胞培养研究中 ,观察Adefovir抗HBV的作用。方法 以乙型肝炎病毒 (HBV)DNA转染的细胞株 2 .2 .15细胞为靶细胞 ,给药后通过检测细胞培养液中HBsAg、HBeAg和HBVDNA ,对Adefovir抗HBV效果进行评价。在2 .2 .15细胞培养基中分别加入不同浓度的药物 ,培养数天后检测上清液中HBsAg和HBeAg滴度 ,细胞DNA抽提液检测HBVDNA ;用四甲基偶氮唑盐 (MTT)比色分析法检测药物对细胞的毒性。结果 Adefovir加入细胞培养 12d ,最大无毒浓度为 2 0 μg/ml,对HB sAg抑制率为 5 2 .4 4 % ,对HBeAg抑制率为 5 4 .87% ,对HBVDNA抑制率为 4 5 .6 8% ,并有剂量依赖效应。结论 Adefovir在体外细胞培养的实验中有抗HBV病毒作用。 Objective To investigate the effect of anti-HBV of Adefovir in vitro. Method The 2.2.15 cell line were treated with series concentrations of Adefovir, then the HBsAg and HBeAg in the supernatant and HBVDNA both in supernatant and cell were measured with commercial detective kits. At the same time the cell vitality also was tested with MTT method for evaluating the cyto-toxic effect of Adefovir. Result After 12d,Adefovir showed no cyto-toxic effect on 2.2.15 cell in the concentration under 20mg/ml. The inhibitive rates were 52.44% for HBsAg, 54.87 for HBeAg, and 45.68% for HBVDNA with the dose-dependent.Conclusion Adefovir shows the anti-HBV action in 2.2.15 cell line culture.
出处 《重庆医学》 CAS CSCD 2004年第11期1690-1691,共2页 Chongqing medicine
关键词 ADEFOVIR 2.2.15细胞 乙型肝炎病毒 Adefovir 2.2.15 cell line HBV
  • 相关文献

参考文献3

二级参考文献27

  • 1陈压西,郭树华,张定凤,陈学华.重庆麻鸭乙肝动物模型的建立及应用——21种中药抗鸭乙型肝炎病毒初筛研究[J].中西医结合肝病杂志,1994,4(3):25-27. 被引量:29
  • 2Morrey JD, Bailey KW, Korba BE, et al. Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine. Antiviral. 1999, 42: 97-108.
  • 3Junker-Niepmann M, Bartenschlager R, Schaller H. A short cisacting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMEO,1990, 9: 3389-3396.
  • 4Guidotti LG, Matzke B, Schaller H, et al. High-level hepatitis B virus replication in transgenic mice. J Virol, 1995, 69: 6158-6169.
  • 5Kajino K, K.amiya N, Yuasa S, et aL Evaluation of anti-hepatitis B virus (HBV) drugs using the HBV transgenic mouse. Application of the semiquantitative polymerase chain reaction (PCR) for serum HBV DNA to monitor the drug efficacy. Biochem Biophys Res Commun, 1992, 241: 43-48.
  • 6Reifenberg K, Wilts H, Lohler J, et al. The hepatitis B virus X protein transactivates viral core gene expression in vivo.J Virol,1999, 73: 10399-10405.
  • 7Araki K, Miyazaki J, Hino O, et al. Expression and repllication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci USA, 1989, 86: 207-211.
  • 8Farza H, Hadchouel M, Scotto J, et al. Replication and gene expression of hepatitis B virus in a transgenic mouse that contain the complete viral genome. J Virol, 1988, 61: 4144-4152.
  • 9Farrell GC, et al. Drugs, 2000;60(4):701-710
  • 10Hussain M, et al. J Viral Hepat, 1999;6(3):183-194

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部